HSBC Holdings
SQZ

HSBC Holdings’s SQZ Biotechnologies Company SQZ Stock Holding History

HSBC Holdings’s Portfolio SQZ Stock Details SQZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-11,440
Closed -$3.11K – 2932
2023
Q2 		$3.11K Hold
11,440
– – ﹤0.01% 2540
2023
Q1 		$6.52K Hold
11,440
– – ﹤0.01% 2630
2022
Q4 		$8.12K Hold
11,440
– – ﹤0.01% 3032
2022
Q3 		$27K Sell
11,440
-55
-0.5% -$165 ﹤0.01% 2861
2022
Q2 		$37K Buy
+11,495
New +$41.4K ﹤0.01% 3163

Other funds holding SQZ

AIG
American International Group New York $609M AUM 23.67% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
BTI
Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return
BSB
Bangor Savings Bank Bangor, Maine $1.36B AUM 19.29% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

HSBC Holdings's SQZ Position: Q3 2023 in Review

HSBC Holdings sold out of SQZ Biotechnologies Company (SQZ) in Q3 2023, closing a stake of 11,440 shares — an estimated $3.11K sold.

HSBC Holdings first reported a position in SQZ in Q2 2022 and held it in 5 quarters. The position peaked at $37K in Q2 2022. 5 funds tracked by Wall St. Rank hold SQZ as of Q3 2023.

  • HSBC Holdings reported no remaining SQZ Biotechnologies Company position as of Q3 2023 after selling out during the quarter.
  • HSBC Holdings sold 11,440 SQZ Biotechnologies Company shares in Q3 2023, an estimated $3.11K.
  • HSBC Holdings first reported a position in SQZ Biotechnologies Company in Q2 2022 and held it in 5 quarters.
  • HSBC Holdings's SQZ Biotechnologies Company position peaked at $37K in Q2 2022.
  • 5 funds tracked by Wall St. Rank held SQZ Biotechnologies Company as of Q3 2023.

Based on HSBC Holdings's 13F filing for Q3 2023, filed 13 Nov 2023.